| Income Statement |
| Total Revenue | 36.84M |
|
| Revenues (USD) | 36.84M |
| Gross Profit | 36.84M |
| Operating Expenses | 13.55M |
| Research and Development Expense | 8.98M |
| Selling, General and Administrative Expense | 4.60M |
| Operating Income | 23.29M |
| Net Income | 24.13M |
| Net Income Common Stock | 24.13M |
| Net Income Common Stock (USD) | 24.13M |
| Consolidated Income | 24.13M |
| Earnings per Basic Share | 1.94 |
| Earnings per Basic Share (USD) | 1.94 |
| Earnings per Diluted Share | 1.65 |
| Earning Before Interest & Taxes (EBIT) | 24.13M |
| Earning Before Interest & Taxes (USD) | 24.13M |
| Weighted Average Shares | 12.41M |
| Weighted Average Shares Diluted | 14.63M |
| Balance Sheet |
| Cash and Equivalents | 98.09M |
| Cash and Equivalents (USD) | 98.09M |
| Current Assets | 98.81M |
| Total Assets | 98.81M |
| Current Liabilities | 6.88M |
| Total Liabilities | 8.85M |
| Accumulated Retained Earnings (Deficit) | -302.56M |
| Shareholders Equity | 89.96M |
| Shareholders Equity (USD) | 89.96M |
| Assets Non-Current | 5.00K |
| Deferred Revenue | 1.83M |
| Liabilities Non-Current | 1.97M |
| Trade and Non-Trade Payables | 6.82M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1000 |
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.15M |
| Net Cash Flow from Operations | 9.15M |
| Share Based Compensation | 1.39M |